FALCO HOLDINGS Co., Ltd (JP:4671)

:4671

4671

FALCO HOLDINGS Co., Ltd

RESEARCH TOOLSreports

FALCO HOLDINGS Co., Ltd (4671) Price & Analysis

0 Followers

4671 Stock Chart & Stats

¥2681.00

-¥4.00(-0.17%)

At close: Jan 08 4:00 PM EST

¥2681.00

-¥4.00(-0.17%)

Day’s Range― - ―

52-Week Range¥2,125.00 - ¥2,775.00

Previous CloseN/A

Volume5.90K

Average Volume (3M)15.38K

Market Cap

¥25.93B

Enterprise Value¥18.32B

Total Cash (Recent Filing)¥9.32B

Total Debt (Recent Filing)¥1.24B

Price to Earnings (P/E)11.1

Beta0.62

Next Earnings

May 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.81%

Share Statistics

EPS (TTM)60.64

Shares Outstanding10,680,177

10 Day Avg. Volume10,950

30 Day Avg. Volume15,383

Financial Highlights & Ratios

PEG Ratio0.64

Price to Book (P/B)0.97

Price to Sales (P/S)0.57

P/FCF Ratio15.96

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)182.7

Revenue Forecast (FY)¥43.60B

Bulls Say, Bears Say

Bulls Say

Low Leverage / Strong Balance SheetVery low leverage gives the company durable financial flexibility: it can fund operations, absorb cyclical downturns in testing demand, and invest in lab capacity or M&A without stressing liquidity. This supports resilience over the next 2–6 months and beyond.

Stable Revenue Base From Clinical Testing ContractsCore business is recurring diagnostic services and long-term provider contracts, a structural demand driver in healthcare. This steady client base underpins predictable volume and supports service-level scale and sustained revenue even if new sales slow.

Historically Positive Operating And Free Cash FlowConsistent positive OCF and FCF across multiple years indicate core cash generation capability. Even with volatility, recurring cash inflows support capex for labs, dividend funding, and working capital needs, preserving operational continuity long term.

Bears Say

Multi-year Revenue DeclineSustained revenue contraction erodes scale advantages and raises questions about market share or pricing. Over several quarters this reduces absolute EBITDA, constrains reinvestment, and makes returning to prior growth levels more difficult without new services or clients.

Material Margin Compression Since 2022Margins have notably deteriorated versus the 2022 peak, shrinking cash available for reinvestment and dividends. If structural cost pressure or pricing weakness persists, profitability and return metrics will remain impaired, limiting strategic flexibility.

Weak Cash Conversion And FCF Step-down In 2025A sharp FCF decline and low cash-to-earnings conversion signal earnings quality and working-capital timing risks. This reduces funds available for capex, acquisitions or payout consistency and increases sensitivity to operational shocks over the medium term.

4671 FAQ

What was FALCO HOLDINGS Co., Ltd’s price range in the past 12 months?

FALCO HOLDINGS Co., Ltd lowest stock price was ¥2125.00 and its highest was ¥2775.00 in the past 12 months.

What is FALCO HOLDINGS Co., Ltd’s market cap?

FALCO HOLDINGS Co., Ltd’s market cap is ¥25.93B.

When is FALCO HOLDINGS Co., Ltd’s upcoming earnings report date?

FALCO HOLDINGS Co., Ltd’s upcoming earnings report date is May 12, 2026 which is in 33 days.

How were FALCO HOLDINGS Co., Ltd’s earnings last quarter?

FALCO HOLDINGS Co., Ltd released its earnings results on Feb 10, 2026. The company reported ¥60.64 earnings per share for the quarter, beating the consensus estimate of N/A by ¥60.64.

Is FALCO HOLDINGS Co., Ltd overvalued?

According to Wall Street analysts FALCO HOLDINGS Co., Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does FALCO HOLDINGS Co., Ltd pay dividends?

FALCO HOLDINGS Co., Ltd pays a Semiannually dividend of ¥62.5 which represents an annual dividend yield of 4.81%. See more information on FALCO HOLDINGS Co., Ltd dividends here

What is FALCO HOLDINGS Co., Ltd’s EPS estimate?

FALCO HOLDINGS Co., Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does FALCO HOLDINGS Co., Ltd have?

FALCO HOLDINGS Co., Ltd has 10,680,177 shares outstanding.

What happened to FALCO HOLDINGS Co., Ltd’s price movement after its last earnings report?

FALCO HOLDINGS Co., Ltd reported an EPS of ¥60.64 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.006%.

Which hedge fund is a major shareholder of FALCO HOLDINGS Co., Ltd?

Currently, no hedge funds are holding shares in JP:4671

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

FALCO HOLDINGS Co., Ltd

FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, microbiology, and radio immunoassay; genetic testing services; and genomic-based drug discovery and biotechnology drug development services. The company also provides medical information technology services; food sanitation and environmental testing services; and food related genetic testing services to food manufacturers, retailers, and restaurants. In addition, it is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical information systems, including @home Dr. electronic medical charts for clinics with concentrated clinical testing, as well as TASCAL for ASP, a medical support system. The company was founded in 1962 and is headquartered in Kyoto, Japan.